Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jacob

Showing results (201-210 of 653) with videos related to

Pageof 66
Sort By:
Clinical Physiology and Biochemistry|January 1, 1990
Determination of elastin peptides in normal and arteriosclerotic human sera by ELISAT Fülöp, S M Wei, L Robert, et al.
Neurology|February 1, 1982
Increased brain uptake of lidocaine during bicuculline-induced status epilepticus in ratsR P Simon, N L Benowitz, J Bronstein, et al.
Journal of Toxicology. Clinical Toxicology|April 1, 1982
Impaired metabolism of methylphenobarbital after a combined drug overdose: treatment by resin hemoperfusionS Pond, P Jacob, M Humphreys, et al.
Annales De Pathologie|December 7, 2006
[Cellular and molecular mechanisms of fibrosis]J-Y Scoazec, F Verrecchia, M-P Jacob, et al.
Clinical Pharmacology and Therapeutics|September 1, 1992
Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow--limited percutaneous absorptionN L Benowitz, P Jacob, P Olsson, et al.
Indian Journal of Ophthalmology|November 27, 2021
Red eye in a red body! What could it be?Ninan P Jacob, Nirupama Kasturi, Amit K Deb, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearanceC P Denaro, M Wilson, P Jacob, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
The effect of liver disease on urine caffeine metabolite ratiosC P Denaro, M Wilson, P Jacob, et al.
Statistics in Medicine|October 9, 2002
Mechanistic modelling in large case-control studies of lung cancer risk from smokingW F Heidenreich, J Wellmann, P Jacob, et al.
Analytical Chemistry|September 1, 1986
Determination of nicotine N-oxide by gas chromatography following thermal conversion to 2-methyl-6-(3-pyridyl)tetrahydro-1,2-oxazineP Jacob, N L Benowitz, L Yu, et al.
Pageof 66

Showing results (201-210 of 653) with videos related to

Sort By:
Pageof 66
Clinical Physiology and Biochemistry|January 1, 1990
Determination of elastin peptides in normal and arteriosclerotic human sera by ELISAT Fülöp, S M Wei, L Robert, et al.
Neurology|February 1, 1982
Increased brain uptake of lidocaine during bicuculline-induced status epilepticus in ratsR P Simon, N L Benowitz, J Bronstein, et al.
Journal of Toxicology. Clinical Toxicology|April 1, 1982
Impaired metabolism of methylphenobarbital after a combined drug overdose: treatment by resin hemoperfusionS Pond, P Jacob, M Humphreys, et al.
Annales De Pathologie|December 7, 2006
[Cellular and molecular mechanisms of fibrosis]J-Y Scoazec, F Verrecchia, M-P Jacob, et al.
Clinical Pharmacology and Therapeutics|September 1, 1992
Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow--limited percutaneous absorptionN L Benowitz, P Jacob, P Olsson, et al.
Indian Journal of Ophthalmology|November 27, 2021
Red eye in a red body! What could it be?Ninan P Jacob, Nirupama Kasturi, Amit K Deb, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearanceC P Denaro, M Wilson, P Jacob, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
The effect of liver disease on urine caffeine metabolite ratiosC P Denaro, M Wilson, P Jacob, et al.
Statistics in Medicine|October 9, 2002
Mechanistic modelling in large case-control studies of lung cancer risk from smokingW F Heidenreich, J Wellmann, P Jacob, et al.
Analytical Chemistry|September 1, 1986
Determination of nicotine N-oxide by gas chromatography following thermal conversion to 2-methyl-6-(3-pyridyl)tetrahydro-1,2-oxazineP Jacob, N L Benowitz, L Yu, et al.
Pageof 66